Skip To Main Content

This website is intended exclusively for the healthcare professionals residing and/or working in Thailand.

Acute coronary syndrome

P2Y12 inhibitors vs. NSAIDs : Latest Evidence for Optimal Antiplatelet Therapy

P2Y12 inhibitors vs. NSAIDs : Latest Evidence for Optimal Antiplatelet Therapy

Keep scrolling to explore ACS updates

[MedTalks With Experts] Clopidogrel in ACS by Dr. Wacin Buddhari

[MedTalks With Experts] Clopidogrel in ACS by Dr. Wacin Buddhari

Watch now to gain clinical insights and optimize ACS patient care.

Comprehensive Insights into ACS: From Platelet Reactivity to Treatment Adherence

Comprehensive Insights into ACS: From Platelet Reactivity to Treatment Adherence

Dual Therapy, FCAPs, and Antiplatelets: Recent Evidence You Should Know

Dual Therapy, FCAPs, and Antiplatelets: Recent Evidence You Should Know

Evolving Insights on DAPT and SAPT: Highlights From Recent Key Trials

Evolving Insights on DAPT and SAPT: Highlights From Recent Key Trials

Optimizing Hypertension Management: Single-Pill Combinations and Key Insights for Better Outcomes

Optimizing Hypertension Management: Single-Pill Combinations and Key Insights for Better Outcomes

Clopidogrel: Rethinking Antiplatelet Strategies for Better Outcomes

Clopidogrel: Rethinking Antiplatelet Strategies for Better Outcomes

ACS Management: Insights on Rare Cases and Emerging Predictors

ACS Management: Insights on Rare Cases and Emerging Predictors

Please log in or register to continue reading.